Global Bleeding Disorders Treatment Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.com

The "Bleeding Disorders Treatment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Bleeding Disorders Treatment market worldwide is projected to grow by US$7.8 Billion, driven by a compounded growth of 7.5%.

Hemophilia A, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$10.9 Billion by the year 2025, Hemophilia A will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.4% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$270.6 Million to the region's size and clout in the next 5 to 6 years. Over US$233.9 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Hemophilia A will reach a market size of US$551 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.1% over the next couple of years and add approximately US$2.2 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

• Bayer AG
• CSL Behring
• Grifols International SA
• Novo Nordisk A/S
• Octapharma AG
• Pfizer, Inc.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Bleeding Disorders Treatment to Witness Steady Growth
• Hemophilia A to Account for Highest Growth
• Total Number of People Worldwide with Bleeding Disorders by Condition: 2017
• Recombinant Coagulation Factor Concentrates to Register Largest Market Share
• Total Recombinant Coagulation Factors Sales of Novo Nordisk
• Global Competitor Market Shares
• Bleeding Disorders Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
• Bleeding Disorders Treatment Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

• A Prelude into Hemophilia Product Sales of Leading Players
• Hemophilia Product Portfolio of Leading Players
• Total Sales of Hemophilia Drugs by Leading Players-2017
• Annual Hemophilia Product Sales of Shire in Billion USD for the years 2015, 2016, and 2017
• Market Share of Novo Nordisk in Haemophilia: 2017
• Total Sales for Novo Nordisk in Haemophilia Segment: 2018
• Select Products in Developmental Stage
• Select Mergers and Acquisitions

3. MARKET TRENDS & DRIVERS

• Increasing Prevalence of Bleeding Disorders to Propel Market Prospects
• Total Number of Patients with Bleeding Disorders for Select Countries: 1999 to 2017
• Total Number Patients with Haemophilia A and Haemophilia B
• Prophylactic Treatment in Hemophilia to Support Market Growth
• Percentage Breakdown of Diagnosis and Treatment Rates in Haemophilia
• Emerging Therapies/ Investments to Spur Market Demand
• New Product Launches/ Approvals to Support Market Growth
• Higher Cost of Drugs to Hinder Bleeding Disorders Treatment

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

• Market Facts & Figures
• US Bleeding Disorders Treatment Market Share (in %) by Company: 2019 & 2025
• Market Analytics

CANADA

• Percentage Breakdown of Total Population in Canada with Hemophilia by Age Group: 2017
• Market Analytics

JAPAN

CHINA

EUROPE

• Market Facts & Figures
• European Bleeding Disorders Treatment Market: Competitor Market Share Scenario (in %) for 2019 & 2025
• Market Analytics

FRANCE

GERMANY

ITALY

UNITED KINGDOM

SPAIN

RUSSIA

REST OF EUROPE

ASIA-PACIFIC

AUSTRALIA

INDIA

SOUTH KOREA

REST OF ASIA-PACIFIC

LATIN AMERICA

ARGENTINA

BRAZIL

MEXICO

REST OF LATIN AMERICA

MIDDLE EAST

IRAN

ISRAEL

SAUDI ARABIA

UNITED ARAB EMIRATES

REST OF MIDDLE EAST

AFRICA

IV. COMPETITION

V. CURATED RESEARCH

For more information about this report visit https://www.researchandmarkets.com/r/lrq3nv

View source version on businesswire.com: https://www.businesswire.com/news/home/20200226005394/en/